NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · IEX Real-Time Price · USD
0.185
-0.035 (-15.82%)
At close: Jul 19, 2024, 4:00 PM
0.190
+0.005 (2.59%)
Pre-market: Jul 22, 2024, 7:07 AM EDT
NLS Pharmaceutics AG Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for NLSP.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for NLSP is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 | Sep '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 14, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $4 | Hold → Strong Buy | Upgrades | $4 | +2,059.83% | Dec 8, 2022 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2022 |
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +3,139.74% | Sep 6, 2022 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Mar 12, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.46
from -0.32
EPS Next Year
-0.46
from -0.46
Revenue Forecast
| Revenue | 2024 | 2025 |
|---|---|---|
| High | n/a | n/a |
| Avg | n/a | n/a |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2024 | 2025 |
|---|---|---|
| High | -0.47 | -0.47 |
| Avg | -0.46 | -0.46 |
| Low | -0.44 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.